Cohance Lifesciences Limited Stock: price and insider trades · India
Cohance Lifesciences Limited: what insiders have been doing
Cohance Lifesciences Limited is a Health Care company. Its directors and officers file their transactions with SEBI (PIT + SAST). Over the twelve months to 28 October 2026, 3 filings were filed, from 2 insiders.
No insider bought on the market over the period, while 1 insider filed 1 sale. The totals exclude 1 filing filed without an amount.
Publication is fast: at least half of the trades appear on SEBI (PIT + SAST) on the same day. This delay matters because a trade only becomes useful information once it is public. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify.
With 3 filings in twelve months, the company is quieter than the median of 4 filings across the 1,893 companies we follow on the same exchange. Over the whole record (from 2023), the tally stands at no purchases and 4 sales.
In the same sector, recent insider purchases at Dynavox Group AB and EssilorLuxottica also feature in our signals. This summary is built from SEBI (PIT + SAST) disclosures alone and does not predict where the share price will go.
Who traded when
BuySaleAnalyst consensus: bullish or bearish?
Analysts rate Cohance Lifesciences Limited Hold (neutral), based on 10 analysts. Average price target: ₹514.00.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2026FY ended March 2026 · cache
- 2,899,996 shares-MarketSEBI:f334311c8909b4005ec71eb687929ad7447baf24
- 80,434,990 shares-CreationSEBI:d6804dd6307b66af3ac8686a3cb63bfbbbf8117e
- 92,390,578 shares-ReleaseSEBI:184699071965797f5e149510489e9a0a69082851
- 34,148,000 shares@ ₹906.0099.6% of flowEquity SharesSEBI:992a5b06ae82204bf1ed52e007eebfa9c0f06e75
- 713,259 shares@ ₹1.00100.0% of flowEquity SharesSEBI:ead8325397640218ab5f857edac74bf26c35a1d2
- 126,538,578 shares@ ₹1.000.4% of flowEquity SharesSEBI:199524ddb5138f5e0352e46c3ee3f2b15ee1d60b
- 127,537,043 shares@ ₹495.00100.0% of flowEquity SharesSEBI:fbdc5d66e1708c5ca83cf9393cd951f2974c402d
- 28,000 shares@ ₹501.772580.3% of flowEquity SharesSEBI:2f801ef647af1656364412cfd90bba89e1bcf834
- 7,000 shares@ ₹482.246619.7% of flowEquity SharesSEBI:95457dca69ea9df5a82b64bf7c5a8e8dbd76f6bd
9 of 9 declarations
About Cohance Lifesciences Limited
Cohance Lifesciences Limited is a company focused on the healthcare and pharmaceutical sector. It is listed on the XBOM.
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
